PD-L1 on the tumor cell membrane can act as a “molecular shield” to suppress the immune system, while intracellular PD-L1, functioning as an RNA-binding protein, can bind and stabilize mRNAs related to DNA damage repair (133, 134), thereby limiting the DNA damage effects induced by BNCT (135, 136). Here, CD274 is linked to neoplasm.